参考文献/References:
[1]Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCANestimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Matsuoka T,Yashiro M.Biomarkers of gastric cancer: current topics and future perspective[J].World J Gastroenterol,2018,24(26):2818-2832.[3]Bertero T,Oldham WM,Grasset EM,et al.Tumor-stroma mechanics coordinate amino acid availability to sustain tumor growth and malignancy[J].Cell Metab,2019,29(1):124-140.e10.[4]Procacci P,Moscheni C,Sartori P,et al.Tumor-Stroma cross-talk in human pancreatic ductal adenocarcinoma: afocus on the effect of the extracellular matrix on tumor cell phenotype and invasive potential[J].Cells,2018,7(10):158.[5]Varricchi G,Pecoraro A,Marone G,et al.Thymic stromal lymphopoietin isoforms, inflammatory disorders, and cancer[J].Front Immunol,2018,9:1595.[6]Kiani A,Kamankesh M,Vaisi-Raygani A,et al.Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer[J].Mol Biol Rep,2020,47(12):9373-9383.[7]Mondal S,Adhikari N,Banerjee S,et al.Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview[J].Eur J Med Chem,2020,194:112260.[8]Cauwe B,Van den Steen PE,Opdenakker G.The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases[J].Crit Rev Biochem Mol Biol,2007,42(3):113-185.[9]Scannevin RH,Alexander R,HaarlanderTM,et al.Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation[J].J Biol Chem,2017,292(43):17963-17974.[10]Dofara SG,Chang SL,Diorio C.Gene polymorphisms and circulating levels of MMP-2 and MMP-9:areview of their role in breast cancer risk[J].Anticancer Res,2020,40(7):3619-3631.[11]Qiao WH,Cao N,Yang L.MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH[J].Oncol Lett,2017,14(3):3268-3274.[12]Huang H.Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances[J].Sensors(Basel),2018,18(10):3249.[13]Bronisz E,Kurkowska-Jastrz?誰bska I.Matrix metalloproteinase 9 in epilepsy: the role of neuroinflammation in seizure development[J].Mediators Inflamm,2016,2016:7369020.[14]Rice A,Cortes E,Lachowski D,et al.GPER activation inhibits cancer cell mechanotransduction and basement membrane invasion via RhoA[J].Cancers (Basel) ,2020,12(2):289.[15]Irani S.Emerging insights into the biology of metastasis: a review article[J].Iran J Basic Med Sci,2019,22(8):833-847.[16]Liu L,Ye Y,Zhu X.MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway[J].Biomed Pharmacother,2019,117:109096.[17]Aman S,Li YN,Cheng YM,et al.DACH1 inhibits breast cancer cell invasion and metastasis by down-regulating the transcription of matrix metalloproteinase 9[J].Cell Death Discov,2021,7(1):351.[18]Zhao CW,Yuan GH,Jiang YM,et al.Capn4 contributes to tumor invasion and metastasis in gastric cancer via activation of the Wnt/β-catenin/MMP9 signalling pathways[J].Exp Cell Res,2020,395(2):112220.[19]Andreuzzi E,Colladel R,Pellicani R,et al.The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis[J].Matrix Biol,2017,64:40-53.[20]Ardi VC,Kupriyanova TA,Deryugina EI,et al.Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis[J].Proc Natl Acad Sci U S A,2007,104(51):20262-20267.[21]Van den Steen PE,Dubois B,Nelissen I,et al.Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)[J].Crit Rev Biochem Mol Biol,2002,37(6):375-536.[22]Bergers G,Brekken R,McMahon G,et al.Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis[J].Nat Cell Biol,2000,2(10):737-744.[23]Jab?覥ońska-Trypuｃ A,Matejczyk M,Rosochacki S.Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs[J].J Enzyme Inhib Med Chem,2016,31(sup1):177-183.[24]Gam DH,Park JH,Kim JH,et al.Effects of Allium sativumstem extract on growth and migration in melanoma cells through inhibition of VEGF, MMP-2, and MMP-9genes expression[J].Molecules,2021,27(1):21.[25]Fields GB.New strategies for targeting matrix metalloproteinases[J].Matrix Biol,2015,44-46:239-246.[26]Monferran S,Paupert J,Dauvillier S,et al.The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9[J].EMBO J,2004,23(19):3758-3768.[27]Voura EB,English JL,Yu HY,et al.Proteolysis during tumor cell extravasation in vitro: metalloproteinase involvement across tumor cell types[J].PLoS One,2013,8(10):e78413.[28]Jafari E,Safinejad S,Dabir S,et al.Study of the relationship between MMP-2 and MMP-9 and Her2/neu overexpression in gastric cancer: clinico- pathological correlations[J].Asian Pac J Cancer Prev,2021,22(3):811-817.[29]刘炳辉,潘冰.胃癌组织中细胞外基质金属蛋白酶诱导因子、基质金属蛋白酶 9、人表皮生长因子受体 2 表达与患者临床特征及预后的相关性研究[J].中国基层医药,2019,26(22):2694-2698.[30]Peduk S,Tatar C,Dincer M,et al.The role of serum CK18, TIMP1, and MMP-9 levels in predicting R0 resection in patients with gastric cancer[J].Dis Markers,2018,2018:5604702.[31]董磊,夏猛,尚康兴,等.胃癌患者手术前后血清VEGF、MMP-2、MMP-9水平变化及其临床意义[J].分子诊断与治疗杂志,2020,12(9):1221-1225.[32]Shen D,Zeng YY,Zhang WJ,et al.Chenodeoxycholic acid inhibits lung adenocarcinoma progression via the integrin α5β1/FAK/p53 signaling pathway[J].Eur J Pharmacol,2022,923:174925.[33]Rocha LA,Learmonth DA,Sousa RA.αvβ3 and α5β1 integrin-specific ligands: from tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine?[J].Biotechnol Adv,2018,36(1):208-227.[34]Hamidi H,Ivaska J.Every step of the way: integrins in cancer progression and metastasis[J].Nat Rev Cancer,2018,18(9):533-548.[35]Miyamoto S, Katz BZ,Lafrenie RM,et al.Fibronectin and integrins in cell adhesion, signaling, and morphogenesis[J].Ann NY Acad Sci,1998,857:119-129.[36]Caliva MJ,Yang WS,Young-Robbins S,et al.Proteomics analysis identifies PEA-15 as an endosomal phosphoprotein that regulates α5β1 integrin endocytosis[J].Sci Rep,2021,11(1):19830.[37]Hou JB,Yan D,Liu YD,et al.The roles of integrin α5β1 in human cancer[J].Onco Targets Ther,2020,13:13329-13344.[38]Folkman J.Angiogenesis[J].Annual Review of Medicine,2006,57(1):1-18.[39]Carmeliet P,Jain RK.Angiogenesis in cancer and other diseases[J].Nature,2000,407(6801):249-257.[40]Oudart JB,Villemin M,Brassart B,et al.F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction[J].Cell Adh Migr,2021,15(1):215-223.[41]Failla CM,Carbo M,Morea V.Positive and negative regulation of angiogenesis by soluble vascular endothelial growth factor receptor-1[J].Int J Mol Sci,2018,19(5):1306.[42]Huang RX,Rofstad EK.Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma[J].J Exp Clin Cancer Res,2018,37(1):92.[43]董小锋,钟敬涛,刘天奇,等.血管生成素-2通过整合素α5β1调控血管包绕的肿瘤细胞巢阳性肝细胞癌的癌巢转移[J].中华医学杂志,2021,101(9):654-660.[44]Miyazaki K,Togo S,Okamoto R,et al.Collective cancer cell invasion in contact with fibroblasts through integrin-α5β1/fibronectin interaction in collagen matrix[J].Cancer Sci,2020,111(12):4381-4392.[45]Miyamoto S,Nagano Y,Miyazaki M,et al.Integrin α5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma[J].Cancer Lett,2022,526:335-345.[46]Xie YH,Ran LQ,Wu ZY,et al.Role of Integrin β1 in the progression and chemo-resistance of esophageal squamous cell carcinoma[J].J Cancer,2022,13(7):2074-2085.[47]Siu MKY,Jiang YX,Wang JJ,et al.PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling[J].Oncogenesis,2020,9(2):24.[48]Pal S,Ganguly KK,Moulik S,et al.Modulation of MMPs by cell surface integrin receptor α5β1[J].Anticancer Agents Med Chem,2012,12(7):726-732.[49]Janouskova H,Maglott A,Leger DY,et al.Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma[J].Cancer Res,2012,72(14):3463-3470.[50]Nakaoka HJ,Tanei Z,Hara T,et al.Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth[J].Oncogenesis,2017,6(5):e334.[51]张杰,贺宇,谢朝辉.整合素α5β1、CD44V3表达与胃癌临床病理特征的关系[J].右江民族医学院学报,2014,36(4):538-539.[52]白兴武,李桃,齐洁敏.整合素α5β1蛋白及mRNA在胃癌组织中的表达及临床意义[J].世界华人消化杂志,2013,21(6):478-483.
相似文献/References:
[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Journal of Medical Information,2018,31(08):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Journal of Medical Information,2018,31(08):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Journal of Medical Information,2018,31(08):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Journal of Medical Information,2018,31(08):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]李虹霞,刘伏山.慢性萎缩性胃炎的中西医治疗[J].医学信息,2022,35(11):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
LI Hong-Xia,LIU Fu-shan.Treatment of Chronic Atrophic Gastritis with Traditional Chinese and Western Medicine[J].Journal of Medical Information,2022,35(08):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
[6]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(08):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[7]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Journal of Medical Information,2018,31(08):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[8]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Journal of Medical Information,2018,31(08):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[9]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息,2018,31(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Journal of Medical Information,2018,31(08):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[10]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Journal of Medical Information,2018,31(08):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]